The announcement by JAC-AMR of its intention to launch an AMR Research Insights series couldn’t be more timely. The series will provide opportunities for the peer review examination, reporting and promotion of the activities, outputs and impact of multicentre collaborations and consortia studies across the globe.
Taking a broad brush approach the series encourages submissions of review articles on trial protocols, trial highlights secondary analysis of published materials and summaries of the work of R&D consortia groups.
If will be a perfect companion to the much welcomed announcement of the $1 billion AMR Action Fund that seeks to bring between 2 and 4 novel antibiotics to market by 2030.
Consortia and companies wishing to submit or explore ideas for publication should contact the Senior Editor, David van Duin in the first instance.
Join us in telling the story of much needed innovation aimed at addressing the slow burning pandemic that is AMR.